Weak immunogenicity after a single dose of SARS-CoV-2 mRNA vaccine in treated cancer patients
Romain Palich, Marianne Veyri, Stéphane Marot, Aurore Vozy, Joseph Gligorov, P. Maingon, Anne‐Geneviève Marcelin, Jean‐Philippe Spano
Topics & Concepts
MedicineImmunogenicitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakVirologyCancerCancer vaccineImmunologyImmunotherapyAntibodyInternal medicineInfectious disease (medical specialty)OutbreakDiseaseSARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyPeripheral Neuropathies and Disorders